BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37625582)

  • 21. Pulmonary artery pulsatility index as a predictor of right ventricular failure in left ventricular assist device recipients: A systematic review.
    Essandoh M; Kumar N; Hussain N; Dalia AA; Wang D; Al-Qudsi O; Wilsak D; Stahl D; Bhatt A; Awad H; Sawyer TR; Iyer MH
    J Heart Lung Transplant; 2022 Aug; 41(8):1114-1123. PubMed ID: 35644726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support.
    Imamura T; Narang N; Kim G; Nitta D; Fujino T; Nguyen A; Grinstein J; Rodgers D; Ota T; Jeevanandam V; Sayer G; Uriel N
    J Card Fail; 2020 Oct; 26(10):863-869. PubMed ID: 32473380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers.
    Schlöglhofer T; Gross C; Abart T; Schaefer AK; Marko C; Röhrich M; Widhalm G; Kaufmann F; Weigel I; Al Asadi H; Karner B; Riebandt J; Wiedemann D; Laufer G; Schima H; Zimpfer D
    J Heart Lung Transplant; 2024 Feb; 43(2):251-260. PubMed ID: 37769887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of aortic valve regurgitation after continuous-flow left ventricular assist device implantation using artificial intelligence trained on acoustic spectra.
    Misumi Y; Miyagawa S; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Maruyama Y; Ueno T; Toda K; Asanoi H; Sawa Y
    J Artif Organs; 2021 Jun; 24(2):164-172. PubMed ID: 33537860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support.
    Imamura T; Narang N; Kim G; Nitta D; Fujino T; Nguyen A; Grinstein J; Rodgers D; Ota T; Raikhelkar J; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2021 Mar; 45(3):297-302. PubMed ID: 33098153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mean Arterial Pressure to Central Venous Pressure Ratio: A Novel Marker for Right Ventricular Failure After Left Ventricular Assist Device Placement.
    Mohamedali B; Doukky R; Karavalos K; Avery E; Bhat G
    J Card Fail; 2017 Jun; 23(6):446-452. PubMed ID: 28365215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality.
    Holley CT; Fitzpatrick M; Roy SS; Alraies MC; Cogswell R; Souslian L; Eckman P; John R
    J Heart Lung Transplant; 2017 Jan; 36(1):91-96. PubMed ID: 27623098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices.
    Topilsky Y; Oh JK; Atchison FW; Shah DK; Bichara VM; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    J Am Soc Echocardiogr; 2011 Feb; 24(2):157-69. PubMed ID: 21281909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of non-invasive ramp testing for HeartMate 3.
    Najjar E; Thorvaldsen T; Dalén M; Svenarud P; Hallberg Kristensen A; Eriksson MJ; Maret E; Lund LH
    ESC Heart Fail; 2020 Apr; 7(2):663-672. PubMed ID: 32037731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
    Kang G; Ha R; Banerjee D
    J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
    Jimenez Contreras F; Mendiola Pla M; Schroder J; Bryner B; Agarwal R; Russell SD; Mirza J; Daneshmand MA; Milano C
    Eur J Cardiothorac Surg; 2022 May; 61(5):1188-1196. PubMed ID: 35167677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.
    Gupta DK; Skali H; Rivero J; Campbell P; Griffin L; Smith C; Foster C; Claggett B; Glynn RJ; Couper G; Givertz MM; Mehra MR; Di Carli M; Solomon SD; Pfeffer MA
    J Heart Lung Transplant; 2014 Apr; 33(4):372-81. PubMed ID: 24582837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation.
    Fujino T; Sayer A; Nitta D; Imamura T; Narang N; Nguyen A; Rodgers D; Raikhelkar J; Smith B; Kim G; LaBuhn C; Jeevanandam V; Burkhoff D; Sayer G; Uriel N
    J Card Fail; 2020 May; 26(5):383-390. PubMed ID: 32027961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms.
    Uriel N; Levin AP; Sayer GT; Mody KP; Thomas SS; Adatya S; Yuzefpolskaya M; Garan AR; Breskin A; Takayama H; Colombo PC; Naka Y; Burkhoff D; Jorde UP
    J Card Fail; 2015 Oct; 21(10):785-91. PubMed ID: 26117282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left-Ventricular Assist Device Impact on Aortic Valve Mechanics, Proteomics and Ultrastructure.
    Stephens EH; Han J; Trawick EA; Di Martino ES; Akkiraju H; Brown LM; Connell JP; Grande-Allen KJ; Vunjak-Novakovic G; Takayama H
    Ann Thorac Surg; 2018 Feb; 105(2):572-580. PubMed ID: 29223417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic parameters at rest predicting exercise capacity in patients supported with left ventricular assist device.
    Kato H; Iwahana T; Ono R; Okada S; Matsumiya G; Kobayashi Y
    J Artif Organs; 2024 Mar; 27(1):7-14. PubMed ID: 36933087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
    Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N
    Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.